Skip to content
Medicines Discovery Catapult
  • Speak to Us
Menu
Menu
  • Therapeutic Areas
  • Capabilities
  • Technologies
  • Impact
  • Collaborators
  • How We Help
    • Success Stories
  • Resources
  • About Us
    • Our Board
    • Our Leadership
    • Our People
    • Careers
  • Speak to Us

Translational Roadmap for the Organs-on-a-Chip Industry toward Broad Adoption

Read the full article at Bioengineering

Read more

Coupling 193 nm Ultraviolet Photodissociation and Ion Mobility for Sequence Characterization of Conformationally-Selected Peptides

Read the full article in the Journal of the American Society for Mass Spectrometry

Read more

Information-rich high-throughput cellular assays using acoustic mist ionisation mass spectrometry

Read the full article at Analyst

Read more

On the shuttling across the blood-brain barrier via tubule formation: Mechanism and cargo avidity bias

Read the full article in Science Advances

Read more

A Scalable Approach Reveals Functional Responses of iPSC Cardiomyocyte 3D Spheroids

Read the full article in SLAS Discovery

Read more

TET2 drives 5hmc marking of GATA6 and epigenetically defines pancreatic ductal adenocarcinoma transcriptional subtypes

Read the full article in Gastroenterology

Read more

Let's Meet

Medicines Discovery Catapult
Block 35, Mereside
Alderley Park, Macclesfield
Cheshire
SK10 4ZF

  • 01625 704 050
  • info@md.catapult.org.uk
  • Get Directions

Get in Touch

  • Speak to Us
  • Working with Us
  • LinkedIn
  • Twitter
  • Youtube
  • About Us
  • COVID-19
  • Lighthouse Lab
  • Privacy Policy
  • Cookie Policy
  • Disclaimer
  • Modern Slavery
  • ESG
  • MDC logo
  • RDT Logo
  • UKRI logo

© 2025 Medicines Discovery Catapult. All rights reserved.

Catapult Network.

  • Catapult Network
  • Cell and Gene Therapy
  • Compound Semiconductor Applications
  • Connected Places
  • Digital
  • Energy Systems
  • High Value Manufacturing
  • Offshore Renewable Energy
  • Satellite Applications